A few pills a day: that is what survival looks like for many ALK-positive lung cancer patients because of targeted therapy treatment. But eventually, all patients develop resistance to this treatment.
No one yet knows what causes this form of lung cancer, and there is no cure.
ALK Positive, a patient-led advocacy group, is leading the effort to fund groundbreaking research. In partnership with GO2, this new research will pursue lower rates of resistance and increased rates of survival.
Your support is more than helpful, it has a genuine impact on the lives of our patients, because more research = more life.
Please, donate or start a fundraiser with us today.
**For any check/cash donations please make sure to indicate which campaign the funds will be credited towards ex: "ALK Positive." Also, for any Wire Transfers, please email email@example.com for more information.